SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 44 filers reported holding SESEN BIO INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $211,411 | +19.4% | 346,859 | -16.6% | 0.00% | – |
Q3 2022 | $177,000 | -38.5% | 415,890 | +16.9% | 0.00% | – |
Q2 2022 | $288,000 | +21.5% | 355,735 | -9.4% | 0.00% | – |
Q1 2022 | $237,000 | -63.0% | 392,713 | -50.0% | 0.00% | -100.0% |
Q4 2021 | $641,000 | +137.4% | 786,075 | +131.1% | 0.00% | – |
Q3 2021 | $270,000 | -49.7% | 340,181 | +192.5% | 0.00% | -100.0% |
Q2 2021 | $537,000 | +16.2% | 116,319 | -34.6% | 0.00% | 0.0% |
Q1 2021 | $462,000 | +507.9% | 177,821 | +216.1% | 0.00% | – |
Q4 2020 | $76,000 | -9.5% | 56,252 | -6.5% | 0.00% | – |
Q3 2020 | $84,000 | +8300.0% | 60,174 | +5296.8% | 0.00% | – |
Q2 2020 | $1,000 | -93.3% | 1,115 | -95.9% | 0.00% | – |
Q1 2020 | $15,000 | -44.4% | 26,915 | +2.5% | 0.00% | – |
Q4 2019 | $27,000 | +68.8% | 26,269 | +93.1% | 0.00% | – |
Q3 2019 | $16,000 | -36.0% | 13,606 | -18.2% | 0.00% | – |
Q2 2019 | $25,000 | -32.4% | 16,631 | -53.6% | 0.00% | – |
Q1 2019 | $37,000 | -51.9% | 35,862 | -33.7% | 0.00% | -100.0% |
Q4 2018 | $77,000 | – | 54,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,523,296 | $16,175,000 | 0.87% |
Avoro Capital Advisors LLC | 6,800,000 | $14,620,000 | 0.67% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,445,557 | $9,558,000 | 0.67% |
NEXTHERA CAPITAL LP | 1,177,000 | $2,531,000 | 0.48% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 3,623,957 | $7,792,000 | 0.24% |
SPHERA FUNDS MANAGEMENT LTD. | 630,000 | $1,355,000 | 0.16% |
Schonfeld Strategic Advisors LLC | 778,100 | $1,673,000 | 0.07% |
Castle Hook Partners LP | 1,012,924 | $2,178,000 | 0.06% |
MYDA Advisors LLC | 50,000 | $108,000 | 0.06% |
DRW Securities, LLC | 250,100 | $538,000 | 0.03% |